AerSale Corporation
NASDAQ:ASLEAirlines, Airports & Air Services
-$0.11 today
- Market cap
- $242.47M
- Beta
- 0.27
- P/E (TTM)
- 25.5
- EPS (TTM)
- $0.25
Volume 0.30M
Average 0.37M
ASLE Depreciation & Amortization
Non-cash asset write-downs added back to net income because no cash left the business.
AerSale CorporationNASDAQ: ASLE
Depreciation & Amortization · Q1 FY2026 · quarter ended Mar 2026
Depreciation & amortization growth accelerates
Q1 FY2026 depreciation & amortization of $6.16M rose 23.2% year over year, ahead of the +13.2% change in trailing-twelve-month depreciation & amortization. Sequentially, it rose 13.2% from the prior quarter. Over 3 fiscal years it compounded at +18.8% a year.
Context
- Depreciation & amortization amounted to 5.9% of revenue in FY2025, up 1.2 pp from a year earlier.
- Depreciation & amortization increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly growth of +23.2% holds above the trailing-twelve-month pace of +13.2%.
Sources:Cash FlowText generated from reported figures; not investment advice.
Depreciation & Amortization history
USD · from the cash flow
- Latest · FY2025
- 19.89M USD
- Year-over-year change
- +21.2%
- 4-year CAGR
- +11.2%
| Period | Period end | Depreciation & Amortization | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 19.89M | +21.2% |
| FY2024 | 2024-12-31 | 16.41M | +51.7% |
| FY2023 | 2023-12-31 | 10.82M | -8.8% |
| FY2022 | 2022-12-31 | 11.86M | -8.8% |
| FY2021 | 2021-12-31 | 13M | — |
Depreciation & Amortization vs competitors
How ASLE compares with its peers on the latest reported figures
- ASLE's LTM Mar 2026 depreciation & amortization of $21.05M is the 6th largest of the 11 companies compared; the peer median is $17.94M.
- Its year-over-year change of +13.2% is the 3rd highest of 11, against a peer median of -3.3%.
- Depreciation & amortization amounts to 6.2% of revenue for ASLE, versus a peer median of 5.9%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $62.3M | -1.3% | -0.4% | 2.8% | |
| LTM Apr 2026 | $52.57M | -5.4% | -2.3% | 12.8% | |
| LTM Mar 2026 | $36.5M | +12.7% | +2.5% | 6.6% | |
| LTM Mar 2026 | $30.5M | +5.0% | — | 21.3% | |
| LTM Mar 2026 | $22.52M | -11.6% | +0.7% | 5.9% | |
| LTM Mar 2026 | $21.05M | +13.2% | +18.8% | 6.2% | |
| LTM Mar 2026 | $13.36M | -44.5% | -9.2% | 21.0% | |
| LTM Mar 2026 | $7.95M | +27.7% | +8.7% | 1.8% | |
SBCSBC Medical Group Holdings Incorporated | LTM Mar 2026 | $2.7M | -20.9% | -23.2% | 1.6% |
| LTM Mar 2026 | $1.86M | -5.9% | +17.9% | 2.5% | |
| LTM Mar 2026 | $44K | +655.0% | +19.7% | — | |
| Peer median (excluding ASLE) | $17.94M | -3.3% | +0.7% | 5.9% | |
Competitors are the stored peer set for ASLE. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Net Income | 36.12M | 43.86M | (5.56M) | 5.85M | 8.58M |
| Depreciation & Amortization | 13M | 11.86M | 10.82M | 16.41M | 19.89M |
| Deferred Income Tax | (3.19M) | (2.39M) | (916K) | 2.03M | 1.39M |
| Stock-Based Compensation | 12.72M | 16.5M | 12.05M | 4.35M | 4.89M |
| Change in Working Capital | 12.51M | (72.07M) | (190.18M) | (19.39M) | (61.49M) |
| Accounts Receivables | (3.34M) | (1.03M) | (4.59M) | (3.97M) | (7.74M) |
| Inventory | (35.67M) | (37.64M) | (168.63M) | (78.03M) | (54.8M) |
| Accounts Payables | 3.6M | 1.16M | 8.77M | 4.29M | (4.54M) |
| Other Working Capital | 47.92M | (34.56M) | (25.72M) | 58.32M | 5.59M |
| Other Non-Cash Items | 7.92M | 2.12M | (363K) | 1.93M | 3.78M |
| Operating Cash Flow | 79.08M | (113K) | (174.15M) | 11.18M | (22.97M) |
| Capital Expenditures | (3.89M) | (15.6M) | (11.36M) | (29.03M) | (6.08M) |
| Acquisitions (Net) | 17.1M | 0 | 14.45M | 0 | 0 |
| Purchases of Investments | 0 | 0 | 0 | 0 | 0 |
| Sales of Investments | 0 | 0 | 0 | 0 | 0 |
| Other Investing Activities | 0 | 56.97M | 0 | 12.9M | 2.22M |
| Investing Cash Flow | 13.2M | 41.37M | 3.09M | (16.13M) | (3.86M) |
| Debt Repayment | 0 | 0 | 36.2M | 3.49M | 71.16M |
| Common Stock Issued | 9.28M | 0 | 566K | 531K | 386K |
| Common Stock Repurchased | 0 | (22.2M) | 0 | 0 | (45M) |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 |
| Other Financing Activities | (694K) | (2.05M) | (7.02M) | (250K) | (37K) |
| Financing Cash Flow | 8.59M | (24.26M) | 29.74M | 3.77M | 26.51M |
| Effect of Forex Changes | (1) | 0 | 0 | 0 | 0 |
| Net Change in Cash | 100.87M | 17M | (141.32M) | (1.18M) | (319K) |
| Free Cash Flow | 75.19M | (15.71M) | (185.51M) | (17.85M) | (29.05M) |
AerSale Corporation
NASDAQ:ASLE
Intrinsic Alpha fair value
Locked
Current Price
$5.08
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.